Quest Diagnostics
DGX · NYSE
$237.12+$2.21 (+0.94%)TodayMarket closed ·
Prev close $234.91
About DGX
- Employees
- 46,000
- Headquarters
- Secaucus, New Jersey
- Listed
- Dec 17, 1996
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- questdiagnostics.com
Leadership
| Name | Title | Since |
|---|---|---|
| James Davis | — | 2013 |
| Sam Samad | — | — |
| Catherine Doherty | — | — |
| Michael Prevoznik | — | — |
| Adrienne Brott | — | — |
| Mark Delaney | — | — |
| Karthik Kuppusamy | — | — |
| Patrick Plewman | — | — |
| Timothy Ring | — | — |
| Robert Carter | — | — |
| Luis Diaz | — | — |
| Tracey Doi | — | — |
| Vicky Gregg | — | — |
| Wright Lassiter | — | — |
| Timothy Main | — | — |
| Denise Morrison | — | — |
| Gary Pfeiffer | — | — |
| Shawn Bevec | — | 2020 |
Revenue by product and region
Fiscal year ended Dec 31, 2019: $7.73B total revenue
By product
- Routine clinical testing services$4.21B54.4%
- Gene-based and esoteric (including advanced diagnostics) testing services$2.62B33.9%
- Anatomic pathology testing services$579.00M7.5%
- All other services$321.00M4.2%
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Siemens Healthineers AG SMMNY | Supplier | 0.79 |
| IQVIA Holdings IQV | Supplier and customer | 0.69 |
| Easterly Government Properties DEA | Supplier | 0.53 |
| ProQR Therapeutics PRQR | Supplier and customer | 0.53 |
| Ginkgo Bioworks A DNA | Supplier and customer | 0.43 |
| Biocept BIOC | Supplier | 0.41 |
| OptimizeRx Corporation OPRX | Supplier | 0.40 |
| ePlus inc. PLUS | Supplier | 0.39 |
| Progyny, Inc. PGNY | Customer | 0.23 |
| Ortho Cli Dgnst Rg OCDX | Supplier | 0.22 |
Similar companies
Companies in the same industry as Quest Diagnostics
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.